Bentham Open Access Article

The Article, “Nano-Level Surface Processing of Fine Particles by Cavitation to Improve the Photocatalytic Properties of Titanium Oxide” of the Journal: Nanoscience & Nanotechnology-Asia, is now Open for all to view and Access.

For information, visit:

 See more at:

For Article Information, visit:

Brand New eBook Podcast!!

Current Diagnosis of infant Tuberculosis Infection by Paulo Antas

Watch the Podcast here:

eBook: “Current Diagnosis of infant Tuberculosis Infection”

Author: Paulo R. Z. Antas

One of the most extraordinary characteristics of Mycobacterium tuberculosis infection is its capacity to remain within the host’s tissues for a long period of time. There is an enormous reservoir of persons latently infected with tuberculosis (LTBI) estimated at about a third of the world’s population.

For more information on the eBook, visit:

Browse eBooks by subject here:

Press Release:

Simplifying the Bioequivalence Testing Process and Optimizing Oral Formulation Development via Unifying the Global Life Science Community this November in San Diego


New York, NY, October 16, 2014 – Curtis & Coulter LLC, a new specialty life science events organizer are under 3 weeks away from hosting theirco-located Bioequivalence: Intersection Between Science & Regulatory Summitand Oral Drug Formulation Innovations Summittaking place on November 5-6 2014 at the Westin San Diego, CA.

November’s events are specifically designed to unify and assist drug development organizations in streamlining the bioequivalence testing process, as well as optimizing formulation development approaches for oral drug products. This will in turn have a positive knock-on effect on approval rates of much-needed future drug products.

“We are delighted that multiple leading players within the global life sciences community share this vision and are thrilled that attendeeswill bejoining us in San Diego from as far afield as China, India, Taiwan, Czech Republic, Brazil, Germany and Italy” stated Mark Coulter, CEO of Curtis & Coulter LLC. “It’s good to know the global life science community is committed to uniteand work towards overcoming bioequivalence and formulation development challenges in order to ensurethat faster, safer, much-needed drug products are readily available”he added.

The two events will include key presentationsfrom Pfizer, Merck, GlaxoSmithKline, Johnson& Johnson amongst other leading drug development organizations. Additionally presenters will include the FDA, and a number of other global regulatory agencies.You can find out more information including program details and registration options by visiting


About Curtis & Coulter LLC

Curtis & Coulter specialize in researching and developing cutting-edge events for the life sciences sector. Each event is designed to bring together industry professionals in a unique format for collaborative learning and networking. Theyprovide an unmatched, innovative user experience to exchange ideas, gain advanced industry knowledge and benchmark with like-minded peers through interactive platforms.

Media Contact:

Lauren Lorey


SMI Event

RNA Therapeutics: 


16TH FEB – 17TH FEB 2015

Marriott Regents Park Hotel, London UK


RNA Therapeutics 2015 returns to London on 16th and 17th February, gathering a room full of scientific pioneers and industry experts to identify the latest advancements, best practice and strategies to maximise return on investment. Hear case study driven presentations from an array of market leaders such as Roche, CRISPR Therapeutics, Leiden University Medical Centre, MiNa Therapeutics and AstraZeneca, discussing CRIPSPR gene editing technologies, hepatic targeting, viral delivery, the patent application process, RNA splicing, plus much more! To register visit Alternatively contact the team on +44 (0) 870 9090 711 or email